2-Chlorodeoxyadenosine treatment in the Sezary syndrome

Blood. 1997 Feb 15;89(4):1462-4.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Adult
  • Aged
  • Antimetabolites, Antineoplastic / adverse effects
  • Antimetabolites, Antineoplastic / therapeutic use*
  • Cladribine / adverse effects
  • Cladribine / therapeutic use*
  • Female
  • Humans
  • Infections / etiology
  • Male
  • Middle Aged
  • Neutropenia / chemically induced
  • Neutropenia / complications
  • Sezary Syndrome / drug therapy*
  • Thrombocytopenia / chemically induced
  • Treatment Failure

Substances

  • Antimetabolites, Antineoplastic
  • Cladribine